Peak Human Thymosin Alpha-1 (TA-1) | 10 mg

Technical Overview 

Thymosin Alpha-1 is a synthetic peptide derived from Prothymosin Alpha. In clinical research, it acts as a precision signaling molecule for the thymus gland. At the 10 mg concentration, it is studied for its ability to provide a more sustained modulation of the adaptive immune system, specifically the maturation of T-lymphocytes.

The “Immune Shield” Research Profile

• T-Cell Differentiation: Researched for its capacity to transform immature stem cells into functional CD4+ and CD8+ T-cells.

• Direct Antiviral Signaling: Investigated for its ability to inhibit viral replication within host cells by enhancing the body’s natural interferon production.

• Homeostatic Regulation: Unlike simple stimulants, TA-1 is studied for its “bi-directional” ability—boosting the immune response when weak and calming it during autoimmune-like hyper-inflammation.

Primary Research Objectives

• Systemic Resilience: Analyzing the subject’s ability to maintain high performance under extreme environmental or biological stress.

• Chronic Pathogen Protocols: A primary candidate for research involving persistent viral or fungal presence where the immune system has reached “exhaustion.”

• Thymic Rejuvenation: Data sets focused on reversing “Thymic Involution” (age-related immune decline).

Quality Standard

• Purity: ≥99% (HPLC Verified).

• Format: Lyophilized powder.

• Reconstitution: 2ml of Bacteriostatic Water is recommended for a 10mg sequence to allow for precise micro-titration.